In vivo parasitological measures of artemisinin susceptibility.

In vivo parasitological measures of artemisinin susceptibility.

Parasite clearance data from 18,699 patients with falciparum malaria treated with an artemisinin derivative in areas of low (n=14,539), moderate (n=2077), and high (n=2083) levels of malaria transmission across the world were analyzed to determine the factors that affect clearance rates and identify...

Descripció completa

Dades bibliogràfiques
Autors principals:	Stepniewska, K, Ashley, E, Lee, S, Anstey, N, Barnes, K, Binh, T, D'Alessandro, U, Day, N, de Vries, P, Dorsey, G, Guthmann, J, Mayxay, M, Newton, P, Olliaro, P, Osorio, L, Price, R, Rowland, M, Smithuis, F, Taylor, W, Nosten, F, White, N
Format:	Journal article
Idioma:	English
Publicat:	2010

Ítems similars

The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria.
per: Lee, S, et al.
Publicat: (2008)

Early parasitological response following artemisinin-containing regimens: a critical review of the literature.
per: Das, D, et al.
Publicat: (2013)

In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.
per: Stepniewska, K, et al.
Publicat: (2004)

Artemisinin combination therapy for vivax malaria.
per: Douglas, N, et al.
Publicat: (2010)

The relationship between the haemoglobin concentration and the haematocrit in <it>Plasmodium falciparum </it>malaria
per: Newton Paul, et al.
Publicat: (2008-08-01)

Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
per: Dahal, P, et al.
Publicat: (2022)

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: A prospective multi-centre individual patient data analysis
per: Zwang, J, et al.
Publicat: (2009)

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.
per: Zwang, J, et al.
Publicat: (2009)

Artemisinin and derivatives in the treatment of uncomplicated malaria.
per: White, N, et al.
Publicat: (1998)

Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription.
per: Mok, S, et al.
Publicat: (2011)

No evidence for spread of Plasmodium falciparum artemisinin resistance to Savannakhet Province, Southern Laos.
per: Mayxay, M, et al.
Publicat: (2012)

A major genome region underlying artemisinin resistance in malaria.
per: Cheeseman, I, et al.
Publicat: (2012)

A major genome region underlying artemisinin resistance in malaria.
per: Cheeseman, I, et al.
Publicat: (2012)

Emergence of artemisinin-resistant malaria on the western border of Thailand: A longitudinal study
per: Phyo, A, et al.
Publicat: (2012)

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.
per: Phyo, A, et al.
Publicat: (2012)

A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites.
per: Nair, S, et al.
Publicat: (2003)

Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia
per: Grist, E, et al.
Publicat: (2016)

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
per: Phyo, A, et al.
Publicat: (2012)

Intrarectal artemisinin derivatives.
per: Nosten, F, et al.
Publicat: (1998)

Artemisinin resistance in Plasmodium falciparum malaria.
per: Dondorp, A, et al.
Publicat: (2009)

Effects of artemisinin derivatives on malaria transmissibility.
per: Price, R, et al.
Publicat: (1996)

Use of artemisinin derivatives for the control of malaria.
per: Nosten, F, et al.
Publicat: (1998)

Artemisinin-based combination treatment of falciparum malaria.
per: Nosten, F, et al.
Publicat: (2007)

Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites.
per: Anderson, T, et al.
Publicat: (2005)

Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives
per: Flegg, J, et al.
Publicat: (2013)

Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies.
per: Lindegardh, N, et al.
Publicat: (2008)

Selection strength and hitchhiking around two anti-malarial resistance genes.
per: Nash, D, et al.
Publicat: (2005)

ARTEMISININ - LARGE COMMUNITY STUDIES
per: Nosten, F
Publicat: (1994)

Artemisinin: large community studies.
per: Nosten, F
Publicat: (1994)

Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a geographical bias
per: Saralamba, N, et al.
Publicat: (2018)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
per: Dondorp, A, et al.
Publicat: (2009)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
per: Das, D, et al.
Publicat: (2013)

Intrahost modeling of artemisinin resistance in Plasmodium falciparum
per: Saralamba, S, et al.
Publicat: (2010)

Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
per: Saralamba, S, et al.
Publicat: (2011)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
per: Price, R, et al.
Publicat: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
per: Price, R, et al.
Publicat: (2007)

Genomic epidemiology of artemisinin resistant malaria.
per: MalariaGEN Plasmodium falciparum Community Project, et al.
Publicat: (2016)

The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong Subregion: a molecular epidemiology observational study
per: Imwong, M, et al.
Publicat: (2017)

The mechanism of artemisinin resistance of Plasmodium falciparum malaria parasites originates in their initial transcriptional response
per: Zhu, L, et al.
Publicat: (2021)

Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya.
per: Andrew Nyandigisi, et al.
Publicat: (2011-01-01)